Secondary Logo

July-September 2018 - Volume 32 - Issue 3

  • Dr. José Luchsinger-Stuart, MD, MPH
  • 0893-0341
  • 1546-4156
  • 4 issues / year
  • Clinical Neurology 134/194
    Pathology 42/79
  • 1.940

Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer’s Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors

Grossberg, George T.; Alva, Gustavo; Hendrix, Suzanne; More

Alzheimer Disease & Associated Disorders. 32(3):173-178, July-September 2018.

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years

Bradfield, Nicholas I.; Ellis, Kathryn A.; Savage, Greg; More

Alzheimer Disease & Associated Disorders. 32(3):190-196, July-September 2018.

Occurrence of Impaired Physical Performance in Memory Clinic Patients With Cerebral Small Vessel Disease

Verwer, Jurre H.; Biessels, Geert-Jan; Heinen, Rutger; More

Alzheimer Disease & Associated Disorders. 32(3):214-219, July-September 2018.

Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients

Lima-Silva, Thaís B.; Bahia, Valéria S.; Cecchini, Mário A.; More

Alzheimer Disease & Associated Disorders. 32(3):220-225, July-September 2018.

Are Informal Caregivers of Persons With Dementia Open to Extending Medical Aid in Dying to Incompetent Patients? Findings From a Survey Conducted in Quebec, Canada

Bravo, Gina; Rodrigue, Claudie; Arcand, Marcel; More

Alzheimer Disease & Associated Disorders. 32(3):247-254, July-September 2018.